Next Article in Journal
Hormone Replacement Therapy and Outcomes for Women with Non-Small-Cell Lung Cancer: Can An Association be Confirmed?
Previous Article in Journal
Metronomic Chemotherapy: Changing the Paradigm That More Is Better
 
 
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Editorial

Screening for Prostate Cancer: Controversy? What Controversy?

1
Department of Immunobiology, University of Arizona College of Medicine, PO Box 245221, Tucson, AZ 85724, USA
2
The Robert Benjamin Ablin Foundation for Cancer Research, Tucson, AZ, USA
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2009, 16(3), 1-2; https://doi.org/10.3747/co.v16i3.459
Submission received: 5 February 2009 / Revised: 5 March 2009 / Accepted: 2 April 2009 / Published: 1 May 2009

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

The purpose of screening is to identify preclinical and asymptomatic cases of a disease in a population at risk—as opposed to making a diagnosis based on a patient’s presentation with symptoms and disease. [...]

Share and Cite

MDPI and ACS Style

Ablin, R.J.; Haythorn, M.R. Screening for Prostate Cancer: Controversy? What Controversy? Curr. Oncol. 2009, 16, 1-2. https://doi.org/10.3747/co.v16i3.459

AMA Style

Ablin RJ, Haythorn MR. Screening for Prostate Cancer: Controversy? What Controversy? Current Oncology. 2009; 16(3):1-2. https://doi.org/10.3747/co.v16i3.459

Chicago/Turabian Style

Ablin, Richard J., and M. R. Haythorn. 2009. "Screening for Prostate Cancer: Controversy? What Controversy?" Current Oncology 16, no. 3: 1-2. https://doi.org/10.3747/co.v16i3.459

Article Metrics

Back to TopTop